Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?-Reference-Cited by-同舟云学术

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?

Published:2008-12 Issue:11 Volume:102 Page:1629-1633
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Avery Kerry N.L.,Metcalfe Chris,Blazeby Jane M.,Lane J. Athene,Neal David E.,Hamdy Freddie C.,Donovan Jenny L.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2008.07879.x/fullpdf

Reference20 articles.

1. Screening for prostate cancer with prostate-specific antigen: beware the biases;Bunting;Clin Chim Acta,2002

2. International trends and patterns of prostate cancer incidence and mortality;Hsing;Int J Cancer,2000

3. Prostate-specific antigen testing in Australia and association with prostate cancer incidence in New South Wales;Smith;Med J Aust,1998

4. What influences men’s decision to have a prostate-specific antigen test? A qualitative study;Rai;Fam Pract,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics Associated with the Use of Diagnostic Prostate Biopsy and Biopsy Outcomes in Australian Men;Cancer Epidemiology Biomarkers & Prevention;2021-06-21

2. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT;Health Technology Assessment;2020-08

3. Predictors of participation in risk-based prostate cancer screening;PLOS ONE;2018-07-10

4. Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP);British Journal of Cancer;2014-05-27

5. Impact of lower urinary tract symptoms on prostate cancer risk among Japanese men with prostate-specific antigen <10 ng/mL and non-suspicious digital rectal examination;International Journal of Urology;2013-03-21